samedan logo

 
 
spacer
home > white papers > Risk-Based Inspection Readiness: Reducing Headaches with Advanced Preparation - The Avoca Group
WHITE PAPERS
logo_The_Avoca_.jpg

The Avoca Group

phone (609) 252-9020
web http://theavocagroup.com/
email 179 Nassau St., Suite 3A, Princeton, NJ 08542

Risk-Based Inspection Readiness: Reducing Headaches with Advanced Preparation

So often, inspections are a major source of stress in the clinical trial environment. This is especially true when processes involved in preparing for an inspection are reactive. But, it doesn’t have to be that way. Using industry-leading practices and resources enables a proactive approach to mitigate—or even eliminate—the pain points associated with preparing for inspections.

The term “risk-based approach” encompasses all activities related to risk-based quality management (RBQM). RBQM is defined as a “systematic process put in place to identify, assess, control, communicate, and review the risks associated with the clinical trial during its lifecycle.


Risk-Based Inspection Readiness: Reducing Headaches with Advanced Preparation
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

3P Biopharmaceuticals renews its “Credit Impôt Recherche” (CIR) by the French Ministry of Higher Education and Research

[Noáin, April 22, 2020] 3P Biopharmaceuticals, a European leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has successfully extended its French CIR certificate for another four-year period: 2020-2024.
More info >>


White Papers

Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands

West Pharmaceutical Services, Inc.

The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >>


Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement